Author

Daniel DeCarvalho

University Health Network

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Alexander J. Murison· 1 shared Alexandra N. Fedor· 1 shared Benjamin Haibe‐KainsiD· 1 shared C.H. ArrowsmithiD· 1 shared David W. CesconiD· 1 shared Felicia TaiiD· 1 shared Geneviève DebloisiD· 1 shared Giacomo GrilloiD· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alexander J. Murison

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Metabolic adaptations underlie epigenetic vulnerabilities in chemoresistant breast cancer.

Geneviève Deblois, Seyed Ali Madani Tonekaboni, Yunchi Ingrid Kao, Felicia Tai, Xiaojing Liu, Ilias Ettayebi, Paul Guilhamon, Alexandra N. Fedor, Giacomo Grillo, Alexander J. Murison, Wail Ba-Alawi, David W. Cescon, C.H. Arrowsmith, Daniel DeCarvalho, Morag Park, , Mathieu Lupien

This study identifies metabolic adaptations in taxane-resistant triple-negative breast cancer cells that lead to epigenetic vulnerabilities, specifically through altered methionine metabolism and H3K27me3 redistribution.

bioRxiv · Mar 28, 2018 · PreprintGenomics